Novel Therapeutic Target Identification through Analysis of Convergent AD and TBI Pathogenic Mechanisms
Technical Report,15 Sep 2017,14 Sep 2018
The Roskamp Institute Sarasota United States
Pagination or Media Count:
We plan to identify and provide preliminary validation for novel targets for the TBI-AD interrelationship discovered through our molecular level profiling. The goal here is to target validation and provision of these therapeutic targets for future studies in drug discovery and preclinical efficacy i.e. IND enabling studies of new therapeutic approaches to the AD sequelae of TBI.
- Medicine and Medical Research
- Magnetic and Electric Field Detection and Detectors